FDA advises consumers not to use certain Claire’s products due to asbestos

The FDA is advising consumers not to use certain Claire’s cosmetic products because they may be contaminated with asbestos fibers.

Samples of the following products tested positive for tremolite asbestos during FDA testing:

Claire’s Eye Shadows – Batch No/Lot No: 08/17
Claire’s Compact Powder – Batch No/Lot No: 07/15
Claire’s Contour Palette – Batch No/Lot No: 04/17

The FDA sampled and had tested targeted cosmetic products following reports of contaminated cosmetics marketed by Claire’s. Testing was conducted on behalf of FDA by the Occupational Safety and Health Administration and AMA Analytical Services, Inc.

Asbestos is a naturally occurring mineral that is often found near talc, an ingredient in many cosmetic products. Asbestos however, is a known carcinogen and its health risks are well-documented. During talc mining, if talc mining sites are not selected carefully and steps are taken to purify the talc ore sufficiently, the talc may be contaminated with asbestos.

Consumers who have these batches/lots of Claire’s Eye Shadow, Compact Powder, and Contour in their home should stop using them. Claire’s has informed us that it does not believe that affected products are still available for sale.

The FDA is not aware of any adverse reactions associated with exposure to these Claire’s products. Health care professionals and consumers are encouraged to report any adverse events potentially related to Claire’s Eye Shadow, Compact Powder, and Contour Palette to FDA’s MedWatch Adverse Event Reporting program by:

Completing and submitting the report online at MedWatch Online Voluntary Reporting Form
Downloading and completing the form, then submitting it via fax at 1-800-FDA-0178

The FDA is advising consumers not to use any of the following products.